Candel Therapeutics, Inc. (CADL): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$778.0K
Year ended 2022-12-31
2020-12-31: $91.0K2021-12-31: $232.0K2022-12-31: $778.0K$778.0K
2020-12-31 Depreciation & Amortization (USD) 2022-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2022-12-31$778.0K+235.3%2023-03-30, From 2022-01-01
2021-12-31$232.0K+154.9%2023-03-30, From 2021-01-01
2020-12-31$91.0Kn/a2022-03-29, From 2020-01-01